Neumora Therapeutics, Inc. (NMRA)
2.02
-0.11
(-5.16%)
USD |
NASDAQ |
Jan 16, 16:00
2.06
+0.04
(+1.98%)
After-Hours: 20:00
Neumora Therapeutics Market Cap: 337.52M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ventyx Biosciences, Inc. | 991.17M |
| Puma Biotechnology, Inc. | 320.99M |
| Nautilus Biotechnology, Inc. | 252.61M |
| ProKidney Corp. | 324.14M |
| MapLight Therapeutics, Inc. | 771.34M |
Market Cap Related Metrics
| Price to Book Value | 2.554 |
| Price | 2.02 |
| Earnings Yield | -72.44% |